Ownership history in Carmignac Gestion · 25 quarters on record
This page tracks every 13F SEC filing in which Carmignac Gestion reported a position in CLEARSIDE BIOMEDICAL INC (CLSD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 100,556 | -1,407,786 | -93.3% | 0.01% | $399K | $3.97 |
| 2025 Q2 | UNCHANGED | 1,508,342 | — | 0% | 0.02% | $1.2M | $12.00 |
| 2025 Q1 | REDUCED | 1,508,342 | -425,189 | -22.0% | 0.02% | $1.4M | $13.77 |
| 2024 Q4 | UNCHANGED | 1,933,531 | — | 0% | 0.03% | $1.8M | $14.25 |